Yu no bɔt di APOE Jin Tɛst? Lɛ wi tɔk bɔt am!

Yu kin dɔn yɛri bɔt di `APOE` jin tɛst sɔmsay, ɔ yu nɔ kin yɛri. Dis na rili wan tɛst we dɛn kin du fɔ tɛst pɔsin in jɛnɛtiks. i de chεk us kayn jin (`jεnotayp`) yu dכn kכl apolipoprotein E (`apolipoprotein E (APOE)`). Dis impɔtant bikɔs if yu gɛt sɔm `APOE` jin vayriɔnt dɛm, yu kin gɛt ay risk fɔ gɛt Alzaima sik. Bɔt nɔ fred we yu yɛri dis. Wi go tɔk bɔt ɔl dis klia wan ɛn simpul wan insay dis atikul.

Wetin na di `APOE` jin? Wi gɛt wan na wi bɔdi?

yes, di `APOE` jin na jin we de gi instrכkshכn to wi sεl dεm. fכ bi prεsis, dis jin de tεl wi sεl dεm fכ mek wan protin we dεn kכl `apolipoprotein E`. dis protin rili imכtant biכs i de kam togεda wit fεt dεm (`lipids`), lεk kכlestכl, na wi bכdi fכ mek `lipoprotein` patikyula dεm. na dεn lipoprotein patikyula dεm ya de kכri kכlestכl εn כda fεt dεm tru wi bכdi vεsεl dεm. Fɔ tɔk am simpul wan, i de wok lɛk motoka we de kɛr kɔlɔstrel rawnd wi bɔdi.

tri men tכp dεm, כ alεl dεm de fכ di APOE jin:

• `APOE-e2 (APOE2)`
• `APOE-e3 (APOE3)`
• `APOE-e4 (APOE4)`

Wi ɔl kin gɛt tu kɔpi fɔ di `APOE` jin. Wan frɔm wi mama, wan frɔm wi papa. so yu kin gεt eni kכmbaynshכn fכ eni tu pan di tri `alεl` dεm we wi bin mεnshכn oba. Fɔ ɛgzampul, yu kin gɛt `APOE-e3/e3`, `APOE-e3/e4`, `APOE-e2/e4`, ɛn ɔda tin dɛn.

Dipen pan di kɔmbayn jin dɛm we yu gɛt, di we aw yu bɔdi de transpɔt kɔlɔstrel ɛn ɔda fat dɛm na yu blɔd kin afɛkt, we kin mek yu gɛt sɔm kayn wɛlbɔdi prɔblɛm ɔ i nɔ kin gɛt bɛtɛ wɛlbɔdi.

Us APOE jin variant gɛt fɔ du wit Alzaima sik?

Na sɔmtin wae yu fɔ mɛmba : Dɛn nɔr dɔn fɛn nɔr jin yet fɔ kɔz Alzaima sik dairekt wan. Dat min se, no tin nɔ de we dɛn kɔl "if yu gɛt dis jin, yu go mɔs gɛt Alzaima."

Bɔt risach dɔn sho se if yu gɛt at le wan kɔpi fɔ di jin we dɛn kɔl `APOE-e4 (APOE4)`, yu risk fɔ gɛt Alzaima sik kin go ɔp smɔl. Dis, tu, kin mɔs afɛkt pipul dɛm wae dɔn pas 65 ia, we dɛn kɔl `let-onset Alzheimer's disease`. Nɔr kin bɔrku pipul dɛm wae nɔr rich 65 ia kin gɛt Alzaima sik bak, wae dɛn kin kɔl `early-onset Alzheimer's disease`. Alzaima sik na wan sik wae kin mek pɔrsin nɔr de mɛmba smɔl smɔl, ɔr kin gɛt dis maynia sik.

na di כda say, sכm stכdi dεn sho se fכ gεt di `APOE-e2 (APOE2)` jin vεryכnt de gi sכm protεkshכn εgεst Alzaima sik. ivin if pכsin we gεt dis jin vεryכnt gεt Alzaima sik, i kin apin leta na layf pas pכsin we gεt di `APOE-e4 (APOE4)` jin.

Impɔtant: If yu gɛt mɔ risk nɔ min se yu go mɔs gɛt di sik. I jɔs min se yu kin gɛt dis sik pas ɔda pipul dɛn. Jin na jɔs wan tin we kin afɛkt di risk. Bɔku ɔda tin dɛn kin afɛkt dis.

Aw fɔ chɛk if yu gɛt di `APOE4` jin?

Di APOE jin tɛst na tɛst we dɛn kin du bay dɛnsɛf. Bɔku pipul dɛn kin no bɔt di APOE jin tru di jɛnɛtik tɛst we dɛn kin du na os. Ɔ, if yu want fɔ no yu risk fɔ gɛt Alzaima, yu kin aks yu dɔktɔ bɔt am. Yu kin tink bɔt fɔ du tɛst, mɔ if sɔmbɔdi na yu famili, lɛk yu mama ɛn papa ɔ yu brɔda ɛn sista dɛn, gɛt Alzaima sik (we gɛt famili histri).

If yu dɔn gɛt Alzaima sik, sɔntɛnde dɔktɔ kin tɛl yu fɔ du dis tɛst fɔ ɛp yu fɔ no us tritmɛnt dɛn go fayn fɔ yu.

Di APOE jin tɛst na impɔtant tin bak fɔ di wan dɛn we de du risach, we de kɔmpia di rizɔlt fɔ dɛn tɛst ya wit difrɛn bren imej stɔdi fɔ tray fɔ fɛn nyu ɛn ifektiv tritmɛnt fɔ Alzaima sik.

Wetin kin apin we dɛn de du APOE jenɛtik tɛst? Wetin a fɔ ɛkspɛkt?

Dɛn tin ya kin apin we dɛn de du APOE jenɛtik tɛst:

1. Tek sampul: Dɔktɔ ɔ tren wɛlbɔdi wokman go tek `DNA` sampul frɔm yu. dis kin bi bay we yu tek sכm bכdi (wan `blכd tεst`) כ bay we yu tek sכm sכm sεl dεm frכm insay yu mכt (wan `chεk swab`). Dis na tin we nɔ de mek pɔsin fil pen ɛn we rili simpul .

2. fכ sεnd to di labכtכri: dεn de sεnd di `DNA` sεmpl we dεn gεt to spεshal labכtכri.

3. Tεst: di labכtכri de tεst di DNA sεmpl εn fכ no wetin na yu APOE jin vεryכnt dεm.

4. Tɔk bɔt di rizɔlt: Afta di rizɔlt kam, yu dɔktɔ ɔ pɔsin we de advays yu bɔt di jɛnɛtiks go tɔk to yu bɔt di rizɔlt ɛn wetin dɛn min.

If yu de yuz at-home risk assessment test, yu fɔ rid di instrɔkshɔn dɛn we de kam wit di tɛst kit fayn fayn wan ɛn fala dɛn ɛksaktɔli. Difrɛn kɔmni dɛn kit kin gɛt difrɛn we dɛn fɔ du tin. I bɛtɛ fɔ tɔk bɔt di rizɔlt wit yu dɔktɔ afta yu dɔn gɛt am.

Wetin di rizɔlt fɔ di APOE tɛst min?

di rizulεt dεm fכ wan `APOE` jεnεtik tεst de tεl yu us `APOE` jin alεl dεm yu gεt. Fɔ ɛgzampul, yu rizɔlt go tɛl yu if yu gɛt `APOE-e3/e3`, `APOE-e3/e4`, ɔ `APOE-e2/e3`.

Di rizɔlt fɔ di tɛst kit dɛn na os kin difrɛn smɔl frɔm di rizɔlt we yu kin gɛt frɔm dɔktɔ. If yu gɛt ɛni kwɛstyɔn, yu kin aks di kɔmni we mek di tɛst.

Dɔktɔ ɔ pɔsin we de advays yu bɔt yu jɛnɛtiks go ɛksplen to yu wetin dɛn rizɔlt ya min. Fɔ ɛgzampul, if di tin dɛn we dɔn apin sho se yu gɛt mɔ sik we dɛn kɔl Alzaima, yu dɔktɔ go gi yu advays fɔ ɛp yu fɔ kɔntinyu fɔ gɛt wɛlbɔdi . Fɔ ɛgzampul:

• Fɔ du ɛksɛsayz ɔltɛm ɔ fɔ du ɛksɛsayz.
• Gɛt bɔku slip we yu bɔdi nid.
• Fɔ de wit ɔda pipul dɛn bay we yu de spɛn tɛm wit yu padi ɛn fambul dɛn.
• Fɔ chalenj yu bren wit tin dɛn lɛk fɔ dɔn pazl, fɔ rid buk, ɔ fɔ lan nyu tin.

Apat frɔm dis, yu dɔktɔ kin gi yu ɔda tin dɛn bak we go tɔk bɔt yu wɛlbɔdi prɔblɛm.

Wetin `APOE4` positif min?

`APOE4` positifu min se yu gεt at le wan kכpi fכ di `APOE-e4 (APOE4)` jin na yu `DNA`. dis min se yu jεnεtik mek-ap kin bi `APOE-e3/e4`, `APOE-e4/e4`, כ `APOE-e2/e4`.

Wetin na di prɔbabiliti fɔ gɛt Alzaima if yu gɛt di `APOE4` jin?

akɔdin to stεdi, bitwin 15% εn 25% pan di jεnarכl pipul dεm gεt wan kכpi fכ di `APOE-e4 (APOE4)` jin. כlso, bitwin 2% εn 5% gεt כl tu di kכpi dεm fכ dis jin (`APOE-e4/e4`). Wi dɔn tɔk bɔt se if yu gɛt ivin wan kɔpi fɔ di `APOE4` jin i kin mek yu gɛt Alzaima sik.

Bɔt if yu gɛt dis jin, dat nɔ min se yu go gɛt wan sik we dɛn kɔl Alzaima . Mɛmba se, fɔ tɛst yu jɛnɛtiks nɔto tɛst fɔ no if yu gɛt di sik. I jɔs de asɛs yu risk. I nɔ de kɔnfɔm ɔ pul di sik. Wan pɔsin we de advays yu bɔt yu jɛnɛtiks kin ɛp yu fɔ ɔndastand wetin dɛn tin ya min ɛn wetin yu fɔ du nɛks.

Aw lɔŋ i kin tek fɔ gɛt di rizɔlt fɔ di APOE jenɛtik tɛst?

Bɔku tɛm, i kin tek sɔm dez fɔ mek di rizɔlt fɔ wan APOE jenɛtik tɛst we dɔktɔ du. Bɔt dis tɛm kin difrɛn smɔl dipen pan di ɔspitul ɔ institiushɔn usay yu de du di tɛst. Yu dɔktɔ go ebul fɔ gi yu di rayt tin dɛn.

Test we dɛn kin du na os kin tek ɛnisay frɔm sɔm wiks to sɔm mɔnt fɔ gɛt rizɔlt, i kin dipen pan di kɔmni.

Wi nid fɔ tink bak bɔt di saykilɔjik impak we di infɔmeshɔn we wi gɛt frɔm dis tɛst gɛt.

Wae yu de tɔk bɔt kɔmpleks sik lɛk Alzaima, e kin kɔrej yu fɔ gɛt sɔm ɛksplen, sɔm ansa. Di `APOE` jenɛtik tɛst kin gi sɔm ɛksplen bɔt wetin mek yu kin gɛt Alzaima.

Bɔt di tin dɛn we kin kɔmɔt frɔm yu jenɛtik tɛst kin afɛkt yu difrɛn we dɛn. Di infɔmeshɔn we yu gɛt kin mek yu fil bad, wɔri, fred, ɔ vɛks. Sɔntɛnde, di tin dɛn we go apin nɔ kin bi di ansa we yu bin de op fɔ.

Dɔktɔ kin ɛp yu fɔ pas dis ɛkspiriɛns. Dɛn kin ɛksplen yu tɛst rizɔlt ɛn gi yu ɔl di infɔmeshɔn we yu nid fɔ ɔndastand wetin de apin. I nɔ mata wetin yu jin, sɔm tin dɛn de we yu kin du fɔ mek yu nɔ gɛt Alzaima sik. Yu dɔktɔ na di bɛst pɔsin fɔ gayd yu fɔ plan di nɛks tin dɛn we yu fɔ du.

Fɔ dɔn, di tin dɛn we impɔtant pas ɔl fɔ mɛmba (Take-Home Message) .

So, a op se yu dɔn lan sɔntin we impɔtant frɔm wetin wi dɔn tɔk bɔt di `APOE` jenɛtik tɛst. Fɔ dɔn, mɛmba dɛn pɔynt ya:

• Di APOE jin tɛst jɔs de tɛl yu se yu go gɛt sɔm kayn sik, lɛk Alzaima, bɔt i nɔ min se yu go mɔs gɛt di sik .
• Dis nɔto tɛst fɔ no if pɔsin gɛt sik .
• pan tap we fכ gεt di `APOE-e4 (APOE4)` jin vεryכnt de inkrεs di risk, fכ adopt hεlty layf εn fכ fala mεdikal advays kin εp fכ mεnεj da risk de.
• I rili impɔtant fɔ aks fɔ sɔpɔt frɔm dɔktɔ ɔ jenɛtik kɔstɔma fɔ ɔndastand di tɛst rizɔlt ɛn fɔ manej di saykilɔjik ifɛkt dɛn we gɛt fɔ du wit dɛn.
• I nɔ mata wetin yu jin, fɔ kɔntinyu fɔ gɛt wɛlbɔdi layf (gud it, ɛksesaiz, slip fayn, fɔ gɛt wɛlbɔdi na yu maynd) kin bɛnifit fɔ ɔl yu wɛlbɔdi.

Wi op se yu go si se dis infɔmeshɔn go ɛp yu. If yu gɛt ɛni ɔda kwɛstyɔn, duya nɔ shem fɔ tɔk to dɔktɔ.

` APOE jεnεtik tεst, Alzaima sik, APOE4, jεnεtik risk, dimεnshכn, jεnεtik kכnsεl, hεlth awareness